Aisling Capital Management
Latest statistics and disclosures from Aisling Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BBIO, SNDX, VRNA, ELEV, NUVB, and represent 89.14% of Aisling Capital Management's stock portfolio.
- Added to shares of these 1 stock: TECX.
- Started 1 new stock position in TECX.
- Reduced shares in these 2 stocks: AVRO, SPRB.
- Sold out of its positions in AVRO, SPRB.
- Aisling Capital Management was a net seller of stock by $-854k.
- Aisling Capital Management has $231M in assets under management (AUM), dropping by -21.81%.
- Central Index Key (CIK): 0001766721
Tip: Access up to 7 years of quarterly data
Positions held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 15 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 66.5 | $154M | 6.1M | 25.33 |
|
|
| Syndax Pharmaceuticals (SNDX) | 9.1 | $21M | 1.0M | 20.53 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 7.0 | $16M | 1.1M | 14.46 |
|
|
| Elevation Oncology (ELEV) | 3.3 | $7.7M | 2.8M | 2.70 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 3.2 | $7.4M | 2.5M | 2.92 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 2.5 | $5.8M | 965k | 6.04 |
|
|
| Monte Rosa Therapeutics (GLUE) | 2.4 | $5.5M | 1.5M | 3.74 |
|
|
| Biomea Fusion (BMEA) | 1.6 | $3.6M | 799k | 4.50 |
|
|
| Poseida Therapeutics I (PSTX) | 1.3 | $3.0M | 1.0M | 2.92 |
|
|
| CalciMedica Com New (CALC) | 0.9 | $2.1M | 521k | 3.96 |
|
|
| Marker Therapeutics Com New (MRKR) | 0.7 | $1.7M | 314k | 5.43 |
|
|
| Tectonic Therapeutic (TECX) | 0.6 | $1.4M | NEW | 84k | 16.47 |
|
| Reneo Pharmaceuticals (RPHM) | 0.6 | $1.3M | 886k | 1.51 |
|
|
| Aclaris Therapeutics (ACRS) | 0.2 | $478k | 435k | 1.10 |
|
|
| Viracta Therapeutics (VIRX) | 0.1 | $157k | 289k | 0.54 |
|
Past Filings by Aisling Capital Management
SEC 13F filings are viewable for Aisling Capital Management going back to 2018
- Aisling Capital Management 2024 Q2 filed Aug. 8, 2024
- Aisling Capital Management 2024 Q1 filed May 14, 2024
- Aisling Capital Management 2023 Q4 filed Feb. 7, 2024
- Aisling Capital Management 2023 Q3 filed Nov. 13, 2023
- Aisling Capital Management 2023 Q2 filed Aug. 11, 2023
- Aisling Capital Management 2023 Q1 filed May 9, 2023
- Aisling Capital Management 2022 Q4 filed Feb. 9, 2023
- Aisling Capital Management 2022 Q3 filed Nov. 3, 2022
- Aisling Capital Management 2022 Q2 filed Aug. 10, 2022
- Aisling Capital Management 2022 Q1 filed May 10, 2022
- Aisling Capital Management 2021 Q4 filed Feb. 18, 2022
- Aisling Capital Management 2021 Q3 filed Nov. 12, 2021
- Aisling Capital Management 2021 Q2 filed Aug. 6, 2021
- Aisling Capital Management 2021 Q1 filed May 14, 2021
- Aisling Capital Management 2020 Q4 restated filed Feb. 5, 2021
- Aisling Capital Management 2020 Q4 filed Feb. 4, 2021